Scleroderma is an autoimmune disease characterized by a hard, inflexible layer of skin on the arms, legs and face. In about a third of the cases, the disease, which mainly strikes women aged 30 to 50, ...

Please provide your email address to receive an email when new articles are posted on . Rheumatologists are likely to be at the “forefront” of diagnosing scleroderma skin disorders and other ...

A team of researchers at the Medical University of South Carolina (MUSC) has found that the molecule lysyl oxidase (LOX) plays a number of important roles in promoting skin and organ fibrosis in ...

Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, a new study shows. Results reveal that drugs that inhibit BRD4, known ...

Please provide your email address to receive an email when new articles are posted on . “Health care providers can use our findings to help people with scleroderma to be physically active despite ...

A new 3D tissue model may pave the way for better treatments for the 300,000 Americans affected by scleroderma, a rare immune disease that scars and hardens tissues in the skin and vital organs like ...

GERMANTOWN -- It's a disease that not many people are aware of, let alone able to pronounce. Scleroderma is an autoimmune disease that affects the skin and can be fatal in extreme cases. There is no ...

Systemic sclerosis -- or scleroderma that affects the skin and internal organs -, is one of the rarest autoimmune diseases, affecting roughly 100,000 people (primarily women) in the United ...

For the 300,000 Americans living with the immune disease scleroderma, better treatments can’t come soon enough. The rare and sometimes fatal illness stiffens and scars tissue in organs like the lungs, ...

HIGHLAND PARK, Ill. (WLS) -- A group of women did not wear makeup Sunday and they posted selfies to prove it to raise awareness about a deadly skin disease effecting thousands of men and women. "Face ...

Detection of certain auto-antibodies flagged patients with scleroderma (also known as systemic sclerosis) who were especially likely to develop pulmonary hypertension over long-term follow-up, a ...